| Execution period | May 25, 2026 to June 08, 2026 |
|---|
BSE filing, NSE: BCCFUBA. Summary written from the filing by ALFA Finder's alert engine.
BCC Fuba India Ltd: key numbers
- Share price
- ₹288.40
- Market cap
- ₹571.7 Cr
- Revenue (annual)
- ₹72.65 Cr
- Net profit (annual)
- ₹5.82 Cr
- P/E (TTM)
- 69.4×Sector 44.0×
- Promoter holding
- 32.34%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from BCC Fuba India Ltd
All →BCC Fuba India Capital Structure Change
BCC Fuba India completed conversion of 1,52,357 partly paid-up shares to fully paid-up upon receiving call money. Shares now tradeable under ISIN INE788D01016 effective October 30, 2026.
BCC Fuba India Other Announcement
BCC Fuba India Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes a routine update on promoter dematerialization efforts.
BCC Fuba India Other Announcement
BCC Fuba India Limited has filed the Regulation 74(5) confirmation certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
BCC Fuba India Capital Structure Change
BCC Fuba India's Board approved forfeiture of 8,327 partly paid-up shares for unpaid call money. The forfeited paid-up amount is Rs. 0.03 Crore.
- Value
- ₹0.03 Cr
BCC Fuba India Capital Structure Change
BCC Fuba India converted 1,52,468 partly paid-up rights shares to fully paid-up after receiving ₹0.58 Crore in call money. Paid-up capital now stands at ₹19.90 Crore.
- Value
- ₹0.58 Cr
BCC Fuba India Annual General Meeting
BCC Fuba India Limited held its 40th Annual General Meeting on September 1, 2026, to conduct routine shareholder business and resolutions.
Other fund raise announcements
All →Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.